Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding.

The round was led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT’s E14 Fund, Ubiquity Ventures, and 53 Stations. Vinay Shah, Partner and Founding Team Member at Transformation Capital, will join Ketryx’s board.

The company intends to use ether funds to expand operations and its development efforts.

Led by CEO and Founder Erez Kaminski, Ketryx is a provider of an AI-native compliance platform that automates validation, traceability, and regulatory workflows, including FDA/EU MDR-ready documentation, across the product development lifecycle to help teams release safer products faster.

The platform is already used by medtech companies, Fortune 500 organizations, and AI-powered companies such as DeepHealth, Heartflow, and Aignostics.

The raise brought the total amount to over $55M.

source (finsmes)